In IPF patients, reduced expression and activity of SLC7A11 and GPX4 have been observed, correlating with lung injury and fibrosis progression (Tsubouchi et al., 2019; Chen Tongshuai et al., 2021). The gene discussed is GPX4; the disease is idiopathic pulmonary fibrosis.